Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
SMALL CAP PRO
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Alkermes Plc - Ordinary Shares (MM) | ALKS | NASDAQ | Common Stock | IE00B56GVS15 |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +0 | +0% | 50.54 | - | - | - | 50.54 | 08:19:37 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 49 | 52 | 3 | 5.77% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | - | - | USD |
Alkermes Plc - Ordinary Shares (MM) Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 7.77B | 153.66M | $ -208.44M | -1.38 | 0.00 | 80.42M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | - | 99.50% |
Alkermes Plc - Ordinary Shares (MM) News
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Mon Sep 18, 2017 6:09 PM (2 days ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Mon Sep 18, 2017 5:15 PM (2 days ago)
Patients Switched to Alkermes’ ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms After Inadequate Respons... Business Wire • Mon Sep 18, 2017 7:00 AM (2 days ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Thu Sep 14, 2017 5:24 PM (6 days ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Wed Sep 13, 2017 5:38 PM (7 days ago)
Alkermes Announces 2nd Annual Competitive Grants Program to Support Those Affected by Mental Health and Substance Use Disorders Business Wire • Wed Sep 06, 2017 7:00 AM (2 weeks ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Tue Sep 05, 2017 5:11 PM (2 weeks ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALKS Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 52.93 | 53.58 | 50.46 | 51.9007 | 560k | 2M | 885k | -2.39 | -4.52% |
| 1 Month | 49.87 | 54.4 | 48.9 | 51.0697 | 380k | 2M | 781k | 0.67 | 1.34% |
| 3 Months | 57.51 | 61.98 | 48.9 | 54.3429 | 367k | 2M | 747k | -6.97 | -12.12% |
| 6 Months | 57.5 | 63.4 | 48.9 | 56.5363 | 341k | 2M | 791k | -6.96 | -12.10% |
| 1 Year | 49.94 | 63.4 | 41.93 | 55.6494 | 225k | 14M | 861k | 0.6 | 1.20% |
| 3 Years | 45.44 | 80.71 | 27.14 | 54.4002 | 0 | 14M | 982k | 5.1 | 11.22% |
| 5 Years | 20.88 | 80.71 | 18 | 46.0093 | 0 | 14M | 1M | 29.66 | 142.05% |
Alkermes Plc - Ordinary Shares (MM) Description
| Alkermes PLC is a biotechnology company. It is engaged in developing, manufacturing and commercializing medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious diseases. |
